Last reviewed · How we verify

NCT03472755: MOPHEM

Comparison of Direct Anterior and Posterior Surgical Approaches in Regards to the Patient' Physical Characteristics

Withdrawn NA Last updated 11 December 2020
What this trial tests

NA trial testing The posterolateral approach in Hip Arthropathy. Withdrawn.

Timeline
23 March 2018
Primary endpoint
20 December 2019
20 January 2020

Quick facts

Lead sponsorCentre Hospitalier Universitaire, Amiens
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Start date23 March 2018
Primary completion20 December 2019
Estimated completion20 January 2020

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire, Amiens

Who can join

Adults 50 to 85, any sex, with Hip Arthropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recent increased interest in tissue-sparing and minimally invasive arthroplasty has given rise to a sharp increase in the utilization of direct anterior total hip arthroplasty.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hip Arthropathy

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire, Amiens trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03472755.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing